Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jeffrey Schowinsky

Concepts (129)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Brain Neoplasms
3
2018
743
1.040
Why?
Mycosis Fungoides
2
2018
51
0.970
Why?
Antibodies, Monoclonal, Humanized
3
2017
378
0.740
Why?
Lipomatosis
1
2015
2
0.740
Why?
HMGA2 Protein
1
2015
7
0.730
Why?
Adamantinoma
1
2015
3
0.730
Why?
Synovial Membrane
1
2015
56
0.710
Why?
Eosinophilia
1
2015
121
0.670
Why?
Tibia
1
2015
133
0.640
Why?
Skin Neoplasms
2
2018
649
0.600
Why?
Lymphoma, T-Cell, Peripheral
1
2012
9
0.590
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2012
76
0.540
Why?
Clonal Evolution
2
2017
15
0.390
Why?
Biopsy, Needle
1
2006
201
0.370
Why?
Rectum
1
2006
131
0.360
Why?
Diagnostic Errors
1
2006
140
0.360
Why?
Carrier Proteins
2
2017
799
0.270
Why?
Keratins
2
2015
188
0.260
Why?
Nuclear Proteins
2
2017
653
0.260
Why?
Adenocarcinoma
1
2006
716
0.250
Why?
Fatal Outcome
2
2018
292
0.230
Why?
Fibromatosis, Aggressive
1
2017
16
0.210
Why?
Magnetic Resonance Imaging
4
2016
2342
0.210
Why?
Tetrahydronaphthalenes
1
2017
45
0.210
Why?
Leukemia, Neutrophilic, Chronic
1
2017
5
0.210
Why?
Receptors, Colony-Stimulating Factor
1
2017
9
0.210
Why?
Amyloid Precursor Protein Secretases
1
2017
65
0.210
Why?
Mediastinal Neoplasms
1
2017
48
0.210
Why?
Prostatic Neoplasms
1
2006
1039
0.200
Why?
Valine
1
2017
89
0.200
Why?
Giant Cell Tumor of Bone
1
2016
3
0.200
Why?
Mutation
3
2017
2844
0.200
Why?
Skull Base Neoplasms
1
2016
24
0.200
Why?
Lymphoma
1
2017
176
0.190
Why?
Programmed Cell Death 1 Receptor
1
2017
121
0.190
Why?
Neoplasms, Plasma Cell
1
2015
7
0.190
Why?
Leukocytosis
1
2015
27
0.190
Why?
Lipoma
1
2015
10
0.180
Why?
Tenosynovitis
1
2015
9
0.180
Why?
Gene Frequency
1
2017
507
0.180
Why?
Natalizumab
2
2012
40
0.180
Why?
Soft Tissue Neoplasms
1
2015
62
0.170
Why?
Pyrazoles
1
2017
297
0.160
Why?
Tissue Culture Techniques
1
2013
74
0.160
Why?
Genomic Instability
1
2013
49
0.160
Why?
Humans
16
2018
89065
0.150
Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
16
0.150
Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
33
0.150
Why?
Ki-67 Antigen
1
2012
100
0.140
Why?
CD3 Complex
1
2012
91
0.140
Why?
Mycobacterium Infections, Nontuberculous
1
2015
170
0.140
Why?
Membrane Glycoproteins
1
2015
512
0.140
Why?
Neoplasm Recurrence, Local
1
2016
596
0.140
Why?
Immunologic Factors
1
2012
160
0.130
Why?
Antibodies, Monoclonal
1
2017
1209
0.130
Why?
Middle Aged
5
2018
23512
0.120
Why?
Immunohistochemistry
1
2015
1840
0.120
Why?
Neutrophils
1
2015
1090
0.120
Why?
Bone Marrow
3
2017
206
0.120
Why?
Antineoplastic Agents
2
2017
1880
0.110
Why?
Lymphatic Diseases
1
2008
22
0.110
Why?
Membrane Proteins
1
2015
1070
0.110
Why?
Neutropenia
1
2008
123
0.110
Why?
Neoplasms, Multiple Primary
1
2007
52
0.110
Why?
Racemases and Epimerases
1
2006
8
0.100
Why?
Tomography, X-Ray Computed
2
2016
2050
0.100
Why?
Mucins
1
2006
59
0.090
Why?
Female
8
2017
50643
0.090
Why?
Carcinoma, Renal Cell
1
2007
154
0.090
Why?
Prostate-Specific Antigen
1
2006
158
0.090
Why?
Cell Transformation, Neoplastic
1
2008
336
0.090
Why?
Diagnosis, Differential
2
2007
1420
0.090
Why?
Male
7
2018
50203
0.090
Why?
Leukemia, Myeloid, Acute
1
2008
275
0.090
Why?
Kidney Neoplasms
1
2007
274
0.080
Why?
Liver Neoplasms
1
2007
479
0.080
Why?
Intestinal Mucosa
1
2006
459
0.070
Why?
Adult
5
2016
25891
0.070
Why?
Biomarkers, Tumor
1
2006
773
0.070
Why?
Temporomandibular Joint
1
2016
12
0.050
Why?
Cranial Fossa, Middle
1
2016
5
0.050
Why?
Frontal Bone
1
2016
13
0.050
Why?
Occipital Bone
1
2016
21
0.050
Why?
Leukocyte Count
1
2017
260
0.050
Why?
Sphenoid Bone
1
2016
19
0.050
Why?
Neoplasm, Residual
1
2016
43
0.050
Why?
Temporal Bone
1
2016
57
0.050
Why?
Radiotherapy, Adjuvant
1
2016
206
0.050
Why?
Administration, Oral
1
2017
673
0.050
Why?
Chromosome Aberrations
1
2015
136
0.050
Why?
Recurrence
1
2017
807
0.040
Why?
In Situ Hybridization, Fluorescence
1
2015
318
0.040
Why?
Positron-Emission Tomography
1
2017
316
0.040
Why?
DNA Mutational Analysis
1
2015
412
0.040
Why?
Karyotype
1
2013
4
0.040
Why?
Chondrogenesis
1
2013
39
0.040
Why?
Heterografts
1
2013
92
0.040
Why?
Odds Ratio
1
2016
972
0.040
Why?
Retrospective Studies
2
2017
7773
0.040
Why?
Neoplasm Transplantation
1
2013
267
0.040
Why?
Carcinogenesis
1
2013
80
0.040
Why?
Bone Marrow Cells
1
2013
291
0.040
Why?
Biopsy
1
2015
958
0.040
Why?
Mice, Nude
1
2013
686
0.030
Why?
Protein Kinase Inhibitors
1
2017
702
0.030
Why?
Prognosis
1
2017
2677
0.030
Why?
Disease Progression
1
2017
1920
0.030
Why?
Aged
2
2017
16052
0.030
Why?
Follow-Up Studies
1
2017
4108
0.030
Why?
Genetic Variation
1
2013
811
0.030
Why?
Multiple Sclerosis
1
2012
306
0.030
Why?
Leukocyte Elastase
1
2008
80
0.030
Why?
CD8-Positive T-Lymphocytes
1
2012
497
0.030
Why?
Cytokines
1
2015
1736
0.030
Why?
Cell Line, Tumor
1
2013
2454
0.020
Why?
Aged, 80 and over
1
2017
5511
0.020
Why?
Time Factors
1
2017
6427
0.020
Why?
Cell Differentiation
1
2013
1591
0.020
Why?
Cell Proliferation
1
2013
2048
0.020
Why?
Flow Cytometry
1
2008
1136
0.020
Why?
Treatment Outcome
1
2017
7270
0.020
Why?
Adolescent
1
2017
14618
0.020
Why?
Brain
1
2012
2408
0.020
Why?
Young Adult
1
2013
7703
0.010
Why?
Infant, Newborn
1
2008
4258
0.010
Why?
Mice
1
2013
13679
0.010
Why?
Infant
1
2008
6480
0.010
Why?
Child
1
2008
12781
0.010
Why?
Animals
1
2013
32175
0.010
Why?
Schowinsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2019 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)